Application Sponsors
ANDA 215563 | NOVITIUM PHARMA | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | TABLET;ORAL | 5MG | 0 | BISOPROLOL FUMARATE | BISOPROLOL FUMARATE |
002 | TABLET;ORAL | 10MG | 0 | BISOPROLOL FUMARATE | BISOPROLOL FUMARATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2021-10-29 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
CDER Filings
NOVITIUM PHARMA
cder:Array
(
[0] => Array
(
[ApplNo] => 215563
[companyName] => NOVITIUM PHARMA
[docInserts] => ["",""]
[products] => [{"drugName":"BISOPROLOL FUMARATE","activeIngredients":"BISOPROLOL FUMARATE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"BISOPROLOL FUMARATE","activeIngredients":"BISOPROLOL FUMARATE","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"10\/29\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2021-10-29
)
)